Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Net Margin (2016 - 2025)

Historic Net Margin for Aytu Biopharma (AYTU) over the last 17 years, with Q2 2025 value amounting to 0.41%.

  • Aytu Biopharma's Net Margin rose 89000.0% to 0.41% in Q2 2025 from the same period last year, while for Dec 2025 it was 0.19%, marking a year-over-year increase of 23600.0%. This contributed to the annual value of 0.93% for FY2025, which is 60300.0% up from last year.
  • Aytu Biopharma's Net Margin amounted to 0.41% in Q2 2025, which was up 89000.0% from 0.29% recorded in Q1 2025.
  • In the past 5 years, Aytu Biopharma's Net Margin ranged from a high of 2.3% in Q3 2024 and a low of 220.22% during Q1 2022
  • Moreover, its 5-year median value for Net Margin was 8.45% (2023), whereas its average is 44.99%.
  • As far as peak fluctuations go, Aytu Biopharma's Net Margin tumbled by -1234500bps in 2021, and later surged by 1885500bps in 2023.
  • Quarter analysis of 5 years shows Aytu Biopharma's Net Margin stood at 49.94% in 2021, then skyrocketed by 49bps to 25.47% in 2022, then surged by 82bps to 4.48% in 2023, then soared by 117bps to 0.76% in 2024, then tumbled by -46bps to 0.41% in 2025.
  • Its Net Margin stands at 0.41% for Q2 2025, versus 0.29% for Q1 2025 and 0.76% for Q4 2024.